Good morning :)
Switch to
Place Order

Ajooni Biotech Ltd

AJOONI
Health CarePharmaceuticals
SmallcapWith a market cap of ₹54 cr, stock is ranked 2,226
Moderate RiskStock is 2.94x as volatile as Nifty
54.952.60 (+4.97%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹54 cr, stock is ranked 2,226
Moderate RiskStock is 2.94x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
144.69
PB RatioPB Ratio
3.46
Dividend YieldDiv. Yield
Sector PESector PE
40.61
Sector PBSector PB
5.75
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ajooni Biotech Pvt Ltd is a manufacturer of medicinals and botanicals

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202142.5940.0640.0951.060.390.410.330.38
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.60%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Clarification - Financial Results 
Announced OnJul 11, 2021
The Exchange has sought clarification from Ajooni Biotech Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
The Exchange has sought clarification from Ajooni Biotech Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Copy of Newspaper Publication 
Announced OnJul 8, 2021

Ajooni Biotech Limited has informed the Exchange about Copy of Newspaper Publication | Download

Ajooni Biotech Limited has informed the Exchange about Copy of Newspaper Publication | Download

Updates 
Announced OnJul 8, 2021

Ajooni Biotech Limited has informed the Exchange regarding 'publication of Newspaper regarding achievement of New Milestone in Cattle Feed Supplies for the month of June 2021'. | Download

Ajooni Biotech Limited has informed the Exchange regarding 'publication of Newspaper regarding achievement of New Milestone in Cattle Feed Supplies for the month of June 2021'. | Download

See all events